FDA approves Warner Chilcott ulcerative colitis drug

Drug maker plans to market drug under name Delzicol

DUBLIN — The Food and Drug Administration has approved a new drug from Warner Chilcott for treating ulcerative colitis, the drug maker said.

Warner Chilcott announced the approval of mesalamine in the 400-mg strength.

The company plans to market the drug under the brand name Delzicol and launch it in March.

Login or Register to post a comment.